Richard William Scalzo, Chief Financial Officer at CRESCENT BIOPHARMA, INC. (CBIO), sold 1,112 shares at $17.99 ($20K) on 2026-06-22, disclosed to the SEC on 2026-06-23.
Scheduled sale ($20k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| DYN | SELL | 2025-03-07 | $11K | — | Filing → |
| DYN | SELL | 2025-02-18 | $35K | — | Filing → |
| DYN | SELL | 2024-12-11 | $41K | — | Filing → |